WHO Greenlights Two Ebola Bundibugyo Virus Vaccine Candidates for Phase 2/3 Trials

Coverage, in order

1. 7d ago
   
   first Medical Xpress indie n=5,300

   WHO approves clinical trials on two new Ebola vaccines

   The World Health Organization on Wednesday approved clinical trials for two new Ebola vaccines, as doctors fight to control an outbreak in Africa that has killed more than 5,300 people.

2. 6d ago
   Health Reporters NG indie n=5,300

   WHO Approves Clinical Trials on 2 New Ebola Vaccines

   By Muhammad Amaan The World Health Organisation (WHO) on Wednesday approved clinical trials for two new Ebola vaccines, as doctors fight to control an outbreak in Africa that has killed more than 5,300 people. “Last month, a vaccine trial began using the Ervebo vaccine, which is approved for Ebola…

3. 6d ago
   
   Health Policy Watch Switzerland indie randomized trial

   WHO Greenlights Two Ebola Bundibugyo Virus Vaccine Candidates for Phase 2/3 Trials

   WHO has greenlighted Phase 2/3 trials for two brand new vaccine candidates that specifically target the Ebola Bundibugyo virus species ravaging the Democratic Republic of Congo. Actual trials could forseeably commence “within three to four weeks” – as soon as DRC regulators issue their own…

4. 6d ago
   The Lancet UK indie study n=5000

   [World Report] Bundibugyo vaccine trial begins

   The Tumaini trial is hoping to find effective vaccines against Bundibugyo virus infection, which has killed more than 5000 people in DR Congo. Talha Burki reports.

5. 5d ago
   Pharmaphorum UK indie

   Moderna, Oxford Uni Ebola jabs backed for pivotal testing

   Moderna, Oxford Uni Ebola jabs backed for pivotal testing Phil.Taylor Fri, 06/11/2026 - 11:14

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.